Market Overview

Stocks Hitting 52-Week Lows

Related ONTY
Oncothyreon And Celldex Therapeutics Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 and Varlilumab
UPDATE: H.C. Wainwright & Co. Initiates Coverage On Oncothyreon On Significant Upside
Oncothyreon (ONTY) Stock a Solid Choice Right Now? - Tale of the Tape (Zacks)
Related ICCC
Stocks Hitting 52-Week Lows
Stocks Hitting 52-Week Lows
ImmuCell to Present at LD Micro Conference on December 2, 2014 (GuruFocus)

Oncothyreon (NASDAQ: ONTY) shares lost 56.66% to create a new 52-week low of $1.95. Oncothyreon reported that the pivotal Phase 3 clinical trial of L-BLP25 did not meet its primary endpoint of an improvement in overall survival in patients with non-small cell lung cancer.

ImmuCell (NASDAQ: ICCC) shares fell 1.75% to touch a new 52-week low of $3.93. ImmuCell's trailing-twelve-month ROE is 1.16%.

SinoCoking Coal and Coke Chemical Industries (NASDAQ: SCOK) shares dropped 2.73% to create a new 52-week low of $1.17. SinoCoking Coal and Coke Chemical shares have dropped 47.60% over the past 52 weeks, while the S&P 500 index has gained 16.33% in the same period.

Acorn International (NYSE: ATV) shares declined 3.51% to create a new 52-week low of $2.20. Acorn's trailing-twelve-month operating margin is -5.72%.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets


Related Articles (ICCC + ATV)

Around the Web, We're Loving...

Get Benzinga's Newsletters